26th Annual San Diego Heart Failure Symposium

The 26th Annual San Diego Heart Failure Symposium continues in the tradition of our past programs in providing registrants an update on the latest and most exciting advances in the management of heart failure through a series of didactic lectures.

 

Preventing Cardiovascular Disease and Heart Failure
20:55

26th Annual San Diego Heart Failure Symposium

SGLT2 Inhibitors and GLP-1 Receptor Agonists for Treating Type 2 Diabetes and Reducing Cardiovascular Risk

FEATURING Pam Taub
  • 881 views
  • December 16, 2020
  • 3
13:04

26th Annual San Diego Heart Failure Symposium

Recognizing and Treating Sleep Disordered Breathing: Impact on Patients with Heart Failure and Other Cardiovascular Diseases

FEATURING atul malhotra
  • 21 views
  • December 16, 2020
09:23

26th Annual San Diego Heart Failure Symposium

Q&A: Treating Hyperlipidemia, PAH and Other CV Diseases

FEATURING Barry Greenberg, Pam Taub, Daniel Blanchard, atul malhotra, Nick Kim
  • 24 views
  • December 16, 2020
15:21

26th Annual San Diego Heart Failure Symposium

Advances in Treating Hyperlipidemia: What Are the Results of Trials with PCSK9 Inhibitors and Icosapent Ethyl? What Are the Benefits of Bempedoic Acid and Inclisiran?

FEATURING Pam Taub
  • 923 views
  • December 15, 2020
  • 9
21:22

26th Annual San Diego Heart Failure Symposium

Emerging Concepts in the Use of NOACs in AFib, CAD and DVT: How Do NOACs Compare to Warfarin? Is Rivaroxiban the Best Choice For Preventing VTE Events After Surgery?

FEATURING Daniel Blanchard
  • 214 views
  • December 15, 2020
  • 1
17:57

26th Annual San Diego Heart Failure Symposium

Treating Pulmonary Arterial Hypertension: Overview of FDA Approved Drugs and Importance of Combination Therapy

FEATURING Nick Kim
  • 584 views
  • December 15, 2020
  • 4